Kyle A LaBella
8PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 30, 2024
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model.Yonghong Liu, Jincheng Han, Wen-Hao Hsu
|Sep 29, 2023
Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer.Jincheng Han, Jiaqian Xu, Yonghong Liu
|Sep 28, 2023
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression.Wen-Hao Hsu, Kyle A LaBella, Yiyun Lin
|Jun 21, 2023
Histone demethylase KDM5D upregulation drives sex differences in colon cancer.Jiexi Li, Zhengdao Lan, Wenting Liao
|May 10, 2022
Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer.Rumi Lee, Jiexi Li, Jun Li
|Sep 03, 2021
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.Yohei Yoshihama, Kyle A LaBella, Eiru Kim
Pageof 2
Frequent Collaborators
7 joint publications
Ronald A DePinho
5 joint publications
Denise J Spring
4 joint publications
Jiexi Li
3 joint publications
Chang-Jiun Wu
2 joint publications
Y Alan Wang
2 joint publications
Xiaoying Shang
2 joint publications
Wen-Hao Hsu
2 joint publications
Yiyun Lin
2 joint publications
Christopher Terranova
2 joint publications
Peiwen Chen
